BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Pacific Standard Time
X-LIC-LOCATION:America/Los_Angeles
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:PST
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:PDT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2024 Fall Conference by the ºÃÉ«ÏÈÉú\n\nT
 itle: Industry Therapeutic Update from Biogen: SKYCLARYS® (omaveloxolone)
  The First and Only FDA-Approved Prescription Treatment for Friedreich At
 axia in Adults and Adolescents Aged 16 Years and Older\n\nAccess URL: htt
 ps://www.aan.com/MSA/Public/Events/GetEventURL/17879\n\nLearn More About 
 This Event: /MSA/Public/Events/Details/17879
DTEND;TZID=Pacific Standard Time:20241026T075000
DTSTAMP:20260130T075911Z
DTSTART;TZID=Pacific Standard Time:20241026T070000
LOCATION:/MSA/Public/Events/GetEventURL/17879
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update from Biogen: SKYCLARYS® (omavelox
 olone) The First and Only FDA-Approved Prescription Treatment for Friedre
 ich Ataxia in Adults and Adolescents Aged 16 Years and Older
UID:91637270-7653-4bdc-942e-b2e3e58e0641
END:VEVENT
END:VCALENDAR